Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
This paper presents an immunocytochemical study performed on cytocentrifuged deposits from 109 peritoneal and pleural effusions including 20 transudates, 43 malignant metastatic effusions and 46 effusions containing atypical cells, unidentifiable as reactive mesothelial or malignant epithelial cells on the classical morphological criteria. A panel of four monoclonal antibodies (MAb) was used, including KL1 directed to cytokeratins (KER), V9 to vimentin (VIM), NEO 723 to carcinoembryonic antigen (CEA) and E29 to epithelial membrane antigen (EMA). In most transudates the reactive mesothelial cells coexpressed VIM and KER with a ring-like pattern for the latter proteins. In contrast, they were unreactive to anti-CEA and weakly and inconsistently reactive to anti-EMA. In malignant effusions, most carcinoma cells coexpressed EMA, CEA and KER with a predominant diffuse cytoplasmic pattern for the latter. Only a few malignant epithelial cells from five metastatic adenocarcinomas weakly expressed VIM. When used on the 46 effusions with unidentifiable cells, the panel of MAb allowed reactive mesothelial cells and malignant epithelial cells to be distinguished from each other in 39 of 46 cases (85%).
Daste
G
G
Department of Cell Biology and Cytology, Purpan Hospital, Toulouse, France.
Serre
G
G
Mauduyt
M A
MA
Vincent
C
C
Caveriviere
P
P
Soleilhavoup
J P
JP
D000230:Adenocarcinoma / Q000737:chemistry / Q000473:pathology*; D000911:Antibodies, Monoclonal; D001202:Ascitic Fluid / Q000737:chemistry / Q000473:pathology*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002277:Carcinoma / Q000737:chemistry / Q000473:pathology*; D003581:Cytodiagnosis / Q000379:methods*; D004848:Epithelium / Q000737:chemistry / Q000473:pathology; D005122:Exudates and Transudates / Q000737:chemistry / Q000166:cytology*; D006801:Humans; D007150:Immunohistochemistry; D016130:Immunophenotyping; D007633:Keratins / Q000032:analysis; D008175:Lung Neoplasms / Q000737:chemistry / Q000473:pathology / Q000556:secondary; D008562:Membrane Glycoproteins / Q000032:analysis; D018396:Mucin-1; D016066:Pleural Effusion, Malignant / Q000473:pathology*; D014746:Vimentin / Q000032:analysis
D000911:Antibodies, Monoclonal; D002272:Carcinoembryonic Antigen; D008562:Membrane Glycoproteins; D018396:Mucin-1; D014746:Vimentin; D007633:Keratins